Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis C viral dynamics and immune activation in HCV/HIV coinfected patients treated with pegylated interferon alfa-2a and ribavirin
2005-002202-28Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jun 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of interferon alfa and ribavirin in hepatitis C virus infection, sponsored by Rigshospitalet. Primary endpoints: Hepatitis C viral kinetics and Immune activation parameters. Started Jun 2005; status: completed.
02
Drugs
interferon alfaribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2005-002202-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002202-28.